Midday Report: OrthoPediatrics (KIDS) Trades Higher June 23

Equities Staff  |

OrthoPediatrics corp (NASDAQ: KIDS) shares have risen 5.11%, or $2.225 per share, as on 12:00:34 est today. After Opening the Day at $43.83, 24,902 shares of OrthoPediatrics have been traded today and the stock has moved between $46.27 and $43.83.  

Already the company has a YTD change of 27.28%.

OrthoPediatrics expects its next earnings on 2022-08-03.

For technical charts, analysis, and more on OrthoPediatrics visit the company profile.

About OrthoPediatrics corp

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 44 countries outside the United States.

To get more information on OrthoPediatrics corp and to follow the company's latest updates, you can visit the company's profile page here: OrthoPediatrics corp's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets



Market Movers

Sponsored Financial Content